事業提携・ライセンシング・投資・M&A動向:March 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, March 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, March 2013 9
2.2.1 Medtronic Completes Public Offering of Notes for $3 Billion 9
2.2.2 Lundbeck Enters into Licensing Agreement with Otsuka Pharma for Lu AE58054 9
2.2.3 Edison Pharma Enters Into Licensing Agreement with Dainippon Sumitomo Pharma for EPI-743 and EPI-589 10
2.2.4 Sinopharm Announces Private Placement of Shares for $525 Million 10
2.2.5 AstraZeneca Enters into Co-Development Agreement with Moderna Therapeutics for Messenger RNA Therapeutics 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, March 2013 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, March 2013 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, March 2013 13
3.1.1 Top M&A Deals in March 2013 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, October 2012–March 2013 15
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, March 2013 16
3.2.1 Top Equity Offering Deals in March 2013 17
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, October 2012– March 2013 18
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, March 2013 19
3.3.1 Top PE/VC Deals in March 2013 20
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, March 2013 21
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, March 2013 22
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, October 2012– March 2013 24
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, October 2012– March 2013 25
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2013 26
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2013 26
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, October 2012– March 2013 27
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), March 2013 28
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, March 2013 29
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), October 2012– March 2013 30
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, October 2012– March 2013 31
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), October 2012– March 2013 32
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), October 2012– March 2013 33
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2013 34
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2013 34
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2013 35
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, March 2013 36
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, March 2013 36
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, March 2013 37
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), October 2012– March 2013 38
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), October 2012– March 2013 39
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), October 2012– March 2013 40
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), October 2012– March 2013 42
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 43
6.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, March 2013 43
6.1.1 Central Nervous System – Deals of the Month 44
6.2 Pharmaceuticals & Healthcare, Global, Oncology Deals, March 2013 45
6.2.1 Oncology – Deals of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, March 2013 47
6.3.1 Infectious Diseases – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, March 2013 49
6.4.1 Immunology – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, March 2013 51
6.5.1 Cardiovascular – Deal of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, March 2013 53
6.6.1 Gastrointestinal – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, March 2013 55
6.7.1 Metabolic Disorders – Deal of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, March 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, March 2013 59
7.2.1 Europe – Deals of the Month 60
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, March 2013 61
7.3.1 Asia-Pacific – Deals of the Month 62
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, March 2013 63
7.4.1 Rest of the World – Deals of the Month 64
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 65
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, October 2012– March 2013 65
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, October 2012– March 2013 66
9 Further Information 67
9.1 Methodology 67
9.2 About GlobalData 67
9.3 Contact Us 68
9.4 Disclosure information 68
9.5 Disclaimer 68


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:March 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
■ 発行日:2013年4月12日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160765
■ 調査対象地域:グローバル
  • 世界のG7主要国における膵臓癌治療用スニチニブリンゴ酸塩市場予測
    The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 million by 2021, at a CAGR of 13.9% from 2016 to 2021. The growing incidence of pancreatic cancer (especially pNET) and increasing adoption of sunitinib malate in patients with unrespectable, locally advanced, or metastatic pNET are the major factors driving the sunitinib malate market for pancreatic cancer in G7 Coun …
  • ネットワーク分析のグローバル市場(2014-2018)
    About Network Analytics Network analytics solutions enable network managers to gain a deep understanding of what is happening on their networks through improved visibility and monitoring. Network analytics focuses on network and equipment performance to enable mobile operators to identify network issues in advance. With the help of network analytics solutions operators can manage and enhance the u …
  • 中国のバイオ燃料市場:バイオエタノール、バイオディーゼル、バイオジェット燃料
    About biofuels market in China The continuous growth in the population has led to increased power consumption in the production and transportation sectors. As a result, there is a rise in the level of pollution and GHG. China accounted for 23% of the global energy consumption in the year 2014 according to BP. Over-dependence on coal and oil for power generation and volatile oil prices have increas …
  • 世界及び中国のシクロヘキサンジメタノ—ル(CHDM)市場2015
    The Global Cyclohexane Dimethanol (CHDM) Industry Report 2015 is a professional and in-depth study on the current state of the global cyclohexane Dimethanol industry. The report provides a basic overview of the industry including definitions, classifications, applications, industry chain structure and overview. CHDM market status analysis is provided on both an international basis as well as at ma …
  • Turkiye Petrol Rafinerileri Anonim Sirketi:石油・ガスバリューチェーン分析レポート2013
    Turkiye Petrol Rafinerileri Anonim Sirketi Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Turkiye Petrol Rafinerileri Anonim Sirketi" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Turkiye Petrol Rafinerileri Anonim Sirketi”. The report provides key information relating to oil and gas assets of the company …
  • ニコチン依存症(Nicotine Addiction):世界の治験レビュー(2015年上半期版)
    Nicotine Addiction Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, H1, 2015" provides data on the Nicotine Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitme …
  • 試験・測定装置の世界市場予測(~2024年)
    Test and measurement equipment market to grow at a CAGR of 3.90% from 2018 to 2024The overall test and measurement equipment market is expected to grow from USD 25.7 billion in 2018 to USD 32.3 billion by 2024, at a CAGR of 3.90%. The market is growing due to the increasing demand for this equipment in end-use sectors, such as automotive & transportation, aerospace & defense, IT & telecommunicatio …
  • 医療産業用特殊ガスの世界市場
    ABSTRACTAbout Specialty Gases Specialty gases are a class of high-purity gases that require precise blending of component gases in a gas mixture. Specialized preparation methods and laboratory analysis are used to quantify the component gases in the mixture of gases. This is to obtain high-quality gases with minimal impurities. Advanced production processes, instrumentation, and analytical measure …
  • Continental Resources, Inc.社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
  • Blood Group A Trisaccharideの世界市場
    Blood Group A Trisaccharide (CAS 49777-13-1) Market Research Report 2014 presents comprehensive data on blood group A trisaccharide markets globally and regionally (Europe, Asia, North America etc.) The report includes blood group A trisaccharide description, covers its application areas and related patterns. It overviews blood group A trisaccharide market, names blood group A trisaccharide produc …
  • スペインの麻酔装置・呼吸装置市場
    Spain Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "Spain Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management …
  • 顔認識システムの世界市場2015-2019
    About Facial Recognition Facial recognition is a technology used for the identification of individuals. Facial recognition system measures the overall facial feature of a person such as nose, jaw edges, mouth, and the distance between eyes. Facial recognition is used for access control in restricted or high-security areas such as private and public buildings. Facial recognition is largely used in …
  • 世界の酪農食品(乳製品)市場:ニュース、イベント動向(2014年3月)
    Synopsis The report provides a review of the latest news and key events in the global dairy food market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global dairy food market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global …
  • 随伴水処理サービスの世界市場
    This report estimates the produced water treatment services market in terms of value in $million. This has been broken down into component regions and further split into countries. The oil and gas industry produces large volumes of water every year alongside petroleum. Treatment of produced water is one of the major factors for facilitating the development in environmentally sensitive areas, and c …
  • 世界の金属缶市場2015
    The Global Metal Cans Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Metal Cans industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Metal Cans market analysis is provided for the international markets including development trends, competitive lands …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。